Gene therapy for patients with advanced solid tumors: a phase I study using gene electrotransfer to muscle with the integrin inhibitor plasmid AMEP

References

• Yin H, Kanasty RL, Eltoukhy AA, et al. Non-viral vectors for gene-based therapy. Nat Rev Genet. 2014;15:541–555.
   PubMed Web of Science ®Google Scholar
• Daud AI, DeConti RC, Andrews S, et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol. 2008;26:5896–5903.
   PubMed Web of Science ®Google Scholar
• Neumann E, Schaefer-Ridder M, Wang Y, et al. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J. 1982;1:841–845.
   PubMed Web of Science ®Google Scholar
• Mir LM, Moller PH, Andre F, et al. Electric pulse-mediated gene delivery to various animal tissues. Adv Genet. 2005;54:83–114.
   PubMed Web of Science ®Google Scholar
• Spanggaard I, Corydon T, Hojman P, et al. Spatial distribution of transgenic protein after gene electrotransfer to porcine muscle. Hum Gene Ther Methods. 2012;23:387–392.
   PubMed Web of Science ®Google Scholar
• Lu QL, Bou-Gharios G, Partridge TA. Non-viral gene delivery in skeletal muscle: a protein factory. Gene Ther. 2003;10:131–142.
   PubMed Web of Science ®Google Scholar
• Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012;8:457–465.
   PubMed Web of Science ®Google Scholar
• Hojman P, Gissel H, Gehl J. Sensitive and precise regulation of haemoglobin after gene transfer of erythropoietin to muscle tissue using electroporation. Gene Ther. 2007;14:950–959.
   PubMed Web of Science ®Google Scholar
• Mir LM, Bureau MF, Gehl J, et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA. 1999;96:4262–4267.
   PubMed Web of Science ®Google Scholar
• Draghia-Akli R, Ellis KM, Hill LA, et al. High-efficiency growth hormone-releasing hormone plasmid vector administration into skeletal muscle mediated by electroporation in pigs. FASEB J. 2003;17:526–528.
   PubMed Web of Science ®Google Scholar
• Pavlin D, Tozon N, Sersa G, et al. Efficient electrotransfection into canine muscle. Technol Cancer Res Treat. 2008;7:45–54.
   PubMed Web of Science ®Google Scholar
• Cheresh DA, Stupack DG. Regulation of angiogenesis: apoptotic cues from the ECM. Oncogene. 2008;27:6285–6298.
   PubMed Web of Science ®Google Scholar
• Kim S, Bell K, Mousa SA, et al. Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am J Pathol. 2000;156:1345–1362.
   PubMed Web of Science ®Google Scholar
• Brooks PC, Montgomery AM, Rosenfeld M, et al. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 1994;79:1157–1164.
   PubMed Web of Science ®Google Scholar
• Bosnjak M, Dolinsek T, Cemazar M, et al. Gene electrotransfer of plasmid AMEP, an integrin-targeted therapy, has antitumor and antiangiogenic action in murine B16 melanoma. Gene Ther. 2015;22:578–590.
   PubMed Web of Science ®Google Scholar
• Bosnjak M, Prosen L, Dolinsek T, et al. Biological properties of melanoma and endothelial cells after plasmid AMEP gene electrotransfer depend on integrin quantity on cells. J Membrane Biol. 2013;246:803–819.
   PubMed Web of Science ®Google Scholar
• Trochon-Joseph V, Martel-Renoir D, Mir LM, et al. Evidence of antiangiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidin. Cancer Res. 2004;64:2062–2069.
   PubMed Web of Science ®Google Scholar
• Spanggaard I, Snoj M, Cavalcanti A, et al. Gene electrotransfer of plasmid antiangiogenic metargidin peptide (AMEP) in disseminated melanoma: safety and efficacy results of a phase I first-in-man study. Hum Gene Ther Clin Dev. 2013;24:99–107.
   PubMed Web of Science ®Google Scholar
• Hojman P, Gissel H, Andre FM, et al. Physiological effects of high- and low-voltage pulse combinations for gene electrotransfer in muscle. Hum Gene Ther. 2008;19:1249–1260.
   PubMed Web of Science ®Google Scholar
• Wahl RL, Jacene H, Kasamon Y, et al. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(Suppl.1):122S–150S.
   PubMed Web of Science ®Google Scholar
• Brown PA, Bodles-Brakhop AM, Pope MA, et al. Gene therapy by electroporation for the treatment of chronic renal failure in companion animals. BMC Biotechnol. 2009;9:4.
   PubMed Web of Science ®Google Scholar
• Bodles-Brakhop AM, Brown PA, Pope MA, et al. Double-blinded, Placebo-controlled plasmid GHRH trial for cancer-associated anemia in dogs. MolTher. 2008;16:862–870.
   Google Scholar
• Romeo S, Wu YH, Levine ZA, et al. Water influx and cell swelling after nanosecond electropermeabilization. Biochim Biophys Acta. 2013;1828:1715–1722.
   PubMed Web of Science ®Google Scholar
• Mahmood F, Hansen RH, Agerholm-Larsen B, et al. Detection of electroporation-induced membrane permeabilization states in the brain using diffusion-weighted MRI. Acta Oncol. 2015;54:289–297.
   PubMed Web of Science ®Google Scholar
• Gissel H. Effects of varying pulse parameters on ion homeostasis, cellular integrity, and force following electroporation of rat muscle in vivo. Am J Physiol Regul Integr Comp Physiol. 2010;298:R918–RR29.
   PubMed Web of Science ®Google Scholar
• Bureau MF, Naimi S, Ibad RT, et al. Intramuscular plasmid DNA electrotransfer: biodistribution and degradation. Biochim Biophys Acta. 2004;1676:138–148.
   PubMed Web of Science ®Google Scholar